Genotypic and phenotypic diversity of rabies virus variants involved in human rabies: Implications for postexposure prophylaxis

Journal of Human Virology

Volumn 3, Issue 1, 2000, Pages 50-57

  Dietzschold, Bernard ^a   Morimoto, Kinjiro ^a   Hooper, D Craig ^a   Smith, Jean S ^b   Rupprecht, Charles E ^b   Koprowski, Hilary ^a,c  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Neuropathogenesis; Rabies virus; Silver haired bat; Viral immunity

Indexed keywords

RABIES VACCINE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAT; DOG; FEMALE; GENOTYPE; IMMUNOPATHOGENESIS; IMMUNOTHERAPY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RABIES; TREATMENT OUTCOME; VIRUS ISOLATION; VIRUS MUTATION; VIRUS PATHOGENESIS;

AMINO ACID SEQUENCE; ANIMALS; CELLS, CULTURED; CHIROPTERA; DOGS; GENOTYPE; GTP-BINDING PROTEINS; HUMANS; LETHAL DOSE 50; MICE; MOLECULAR SEQUENCE DATA; PHENOTYPE; RABIES; RHABDOVIRIDAE; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, AMINO ACID; VACCINATION; VIRAL PROTEINS; VIRAL VACCINES;

ANIMALIA; CANIS FAMILIARIS; LASIONYCTERIS; LASIONYCTERIS NOCTIVAGANS; RABIES VIRUS;

EID: 0033926875     PISSN: 10909508     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Rupprecht CE, Smith JS, Fekadu M, Childs JE. The ascension of wildlife rabies: a cause for public health concern or intervention? Emerg Infect Dis 1995;1:107-114.
2. Centers for Disease Control and Prevention. Human rabies - Texas and California, 1993. MMWR Morb Mortal Wkly Rep 1994;43:93-96.
3. Centers for Disease Control and Prevention. Human rabies - California, 1994. MMWR Morb Mortal Wkly Rep 1994;43:455-457.
4. Centers for Disease Control and Prevention. Epidemiologic notes and reports, human rabies - Miami, 1994. MMWR Morb Mortal Wkly Rep 1994;43:773-775.
5. Centers for Disease Control and Prevention. Human rabies - Alabama, Tennessee, and Texas, 1994. MMWR Morb Mortal Wkly Rep 1995;44:269-272.
6. Warrell MJ. Human deaths from cryptic bat rabies in the USA. Lancet 1995;346:65-66.
7. Centers for Disease Control and Prevention. Human rabies - New York, 1993. MMWR Morb Mortal Wkly Rep 1993;42:805-806.
8. Centers for Disease Control and Prevention. Human rabies - Virginia, 1998. MMWR Morb Mortal Wkly Rep 1999;48:93-97.
9. Dietzschold B, Rupprecht CE, Fu ZF, Koprowski H. Rhabdoviruses. In: Fields BN, Knipe DM, Howly PM, eds. Fields Virology, 3rd ed. Philadelphia: Lippincott-Raven, 1996:1137-1159.
10. Murphy FA, Baur SP, Harrison AK, Winn WC. Comparative pathogenesis of rabies and rabies-like viruses: viral infection and transit from inoculation site to the central nervous system. Lab Invest 1973;28:361-376.
11. Charlton KM. The pathogenesis of rabies and other lys-saviral infections. In: Rupprecht CE, Dietzschold B, Koprowski H, editors. Lyssaviruses. Berlin: Springer, 1994: 95-119.
12. Shankar V, Dietzschold B, Koprowski H. Direct entry of rabies virus into the central nervous system without prior local replication. J Virol 1991;65:2736-2738.
13. Morimoto K, Patel M, Corisdeo S, et al. Characterization of a unique variant of bat rabies virus responsible for newly emerging human cases in North America. Proc Natl Acad Sci USA 1996;93:5653-5658.
14. Smith JS, Orciari LA, Yager PA, Seidel HD, Warner CK. Epidemiological and historical relationships among 87 rabies virus isolates as determined by limited sequence analysis. J Infect Dis 1992;166:296-307.
15. Habel K. Habel test for potency. In: Meslin F-X, Kaplan MM, Koprowski H, eds. Laboratory Techniques in Rabies. Monograph Series No. 23, Geneva: World Health Organization, 1966:321-335.
16. Habel K. Habel test for potency. In: Meslin F-X, Kaplan MM, Koprowski H, eds. Laboratory Techniques in Rabies. Geneva: World Health Organization, 1966:369-373.
17. Dietzschold B, Rupprecht CE, Tollis M, Mattei J, Wiktor TJ, Koprowski H. Antigenic diversity of the glycoprotein and nucleocapsid proteins of rabies and rabies-related viruses: implications for epidemiology and control of rabies. Rev Infect Dis 1988;10:5785-5798.
18. Lodmell DL, Smith JS, Esposito JJ, Ewalt LC. Cross-protection of mice against a global spectrum of rabies virus variants. J Virol 1995;69:4957-4962.
19. Smith DB, McAllister J, Casino C, Simmonds P. Virus quasispecies: making a mountain of a molehill? J Gen Virol 1997;78:1511-1519.
20. Morimoto K, Hooper DC, Carbaugh H, Fu ZF, Koprowski H, Dietzschold B. Rabies virus quasispecies: implications for pathogenesis. Proc Natl Acad Sci USA 1998;95-3152-3156.
21. Dietzschold B, Tollis M, Rupprecht CE, Celis E, Koprowski H. Antigenic variation in rabies and rabies-related viruses: cross-protection independent of glycoprotein-mediated virus-neutralizing antibody. J Infect Dis 1987;156:815-822.
22. Koprowski H, Black J. Studies on chick embryo adapted rabies virus IV. Immunization of guinea pigs and description of a potency control test. J Immunol 1954;72: 79-84.